Clinical symptoms and associated vascular imaging findings in Takayasu's arteritis compared to giant cell arteritis.
Despina Michailidou, Joel S Rosenblum, Casey A Rimland...
https://pubmed.ncbi.nlm.nih.gov/31649025/Actively Recruiting
Led by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) · Updated on 2026-08-11
4000
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are studying idiopathic systemic vasculitis, a rare group of diseases that cause inflammation and damage to blood vessels and tissues, affecting both children and adults. These diseases can lead to serious organ damage and have unpredictable relapses. The study aims to understand the signs, symptoms, genetic markers, imaging tests, and blood tests that can help diagnose vasculitis and predict its course over time. Participants include people with known or suspected vasculitis, healthy volunteers, and some related family members. Evaluations include doctor assessments, blood and urine samples, nasal lining biopsies or brushings, and imaging scans of blood vessels using different technologies. Some visits last one to two days, and follow-up visits may occur every three to six months indefinitely. Some tests are done at the NIH, while others involve samples collected by local doctors and sent to NIH. During the study, participants undergo physical exams, laboratory tests, and may complete questionnaires. Imaging and biopsies help researchers study disease mechanisms and outcomes. The research team tracks clinical, radiographic, immunological, and genetic disease characteristics to better understand vasculitis. This long-term study may also identify candidates for future treatment trials. Participation may last many years, with ongoing monitoring and assessments.
CONDITIONS
Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis
S
Shanni Liu
P
Peter C Grayson, M.D.
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 1 to 4 days per visit
Participants receive medical evaluations, provide blood and urine samples, and may undergo nasal biopsies or imaging scans of blood vessels. Some tests are performed at the NIH, while others are done locally with samples sent to NIH.
1 to 2 day visit(s)
Duration - Indefinite
Participants may have follow-up visits every 3 to 6 months indefinitely to monitor disease progression and collect data.
Follow-up visits every 3 to 6 months
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Despina Michailidou, Joel S Rosenblum, Casey A Rimland...
https://pubmed.ncbi.nlm.nih.gov/31649025/Peter C Grayson, Sara Alehashemi, Armin A Bagheri...
https://pubmed.ncbi.nlm.nih.gov/29145713/Carmelo Carmona-Rivera, Monica M Purmalek, Erica Moore...
https://pubmed.ncbi.nlm.nih.gov/28194438/Casey A Rimland, Kaitlin A Quinn, Joel S Rosenblum...
https://pubmed.ncbi.nlm.nih.gov/31785185/Kaitlin A Quinn, Mark A Ahlman, Ashkan A Malayeri...
https://pubmed.ncbi.nlm.nih.gov/29666047/Emily Rose, Marcela A Ferrada, Kaitlin A Quinn...
https://pubmed.ncbi.nlm.nih.gov/33544969/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Lead Sponsor